NCT00867971
Unknown
Not Applicable
Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Growth Hormone Treatment
- Sponsor
- Assaf-Harofeh Medical Center
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Intraoccular pressure in children treated with RGH
- Last Updated
- 17 years ago
Overview
Brief Summary
Recombinant growth hormone is a common therapy in the pediatric population. A number of associated side effects have been described. Several years ago, a case report was published concerning a child that was treated with RGH and developed acute glaucoma. To date no study has evaluated the connection.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 6-18 years
- •treatment with recombinant growth hormone
Exclusion Criteria
- •Underlying Chronic diseases
- •Family history of eye diseases
- •elevated occular pressure prior to starting treatment
Outcomes
Primary Outcomes
Intraoccular pressure in children treated with RGH
Time Frame: 2 years
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
The Effect of Growth Hormone in Very Young Girls With Turner SyndromeTurner SyndromeNCT00406926Eli Lilly and Company100
Completed
Phase 3
Three Times Weekly (TIW) Growth Hormone Therapy in Children on HemodialysisKidney Failure, ChronicRenal DialysisNCT00943995Nationwide Children's Hospital3
Active, not recruiting
Phase 1
Treatment with recombinant Growth Hormone in Children born Small for Gestational Age (SGA) without Catch-up Growth. - Not applicableShort stature in children born small for gestational age without catch up growthEUCTR2005-001507-19-IEational Children's Hospital & Trinity College Dublin350
Active, not recruiting
Not Applicable
Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. - rhGH in JIAGrowth retardation secondary to juvenile idiopathic arthritisEUCTR2004-004153-25-GBRoyal Hospital For Sick Children, Yorkhill Division
Active, not recruiting
Phase 1
Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with Inflammatory bowel disease (IBD) and growth failure. - rhGH in IBDEUCTR2004-002507-32-GBRoyal Hospital For Sick Children, Yorkhill Division60